|
Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Cancer > Research and Development |
| 1. |
Cytogen Corp.
|
|
|
Develops proprietary systems utilizing monoclonal antibodies for the targeted delivery of diagnostic and therapeutic substances in oncology. Includes information for investors, and healthcare professionals in the USA, from Princeton, New Jersey. (Nasdaq: CYTO)
|
| 2. |
ARIAD Pharmaceuticals, Inc.
|
|
|
Develops drugs which block intracellular signal transduction pathways for treating solid tumors and hematologic malignancies. Includes kits available, technology overview and investor data from Cambridge, Massachusetts. (Nasdaq: ARIA)
|
| 3. |
Dendreon Corp.
|
|
|
Discovers and develops immunologically based therapeutic anticancer products. Includes progress of clinical trials, and data for investors from company based in Seattle, Washington. (Nasdaq: DNDN)
|
| 4. |
Exelixis, Inc.
|
|
|
Genomics-based discovery company focused on development of drugs, crop protection, and plant biotechnology. Overview of research, investor relations and contacts in California and Portland, Oregon. (Nasdaq: EXEL)
|
| 5. |
Heal Corporation
|
|
|
Details of projects using resistance related to polyunsaturated fatty acids and catalase in vitro, applied in vivo to trout model. Includes publications, charity status, facilities and contacts in Olympia, Washington.
|
|
|
Add to My Favorite
Refer it to Friend
Report Broken Link
